A New Covid Vaccine That’s Effective Against Omicron Could Hit The Market This Year
Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be [...]
How Health Economics and Outcomes Researchers Can Help Defeat COVID-19
As of October 2, 2020, the novel coronavirus has infected more than 34 million people, including President Donald J. [...]
Private Payers Lead Charge Toward Value-Based Care
Xtelligent Healthcare media has revealed results from a new survey showing that private payers are more likely than public payers [...]
How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton
Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies.
What Are The Recent Top 4 Innovative Consolidations and Partnerships Among Health Payers?
Despite the impacts of the coronavirus pandemic, health payers have still managed to initiate innovative consolidations and partnerships. According to [...]
Where Epidemiologists are Leaning on Kids Returning to School
A recent New York Times Upshot article offers comments from 133 epidemiologists on the matter of children returning to school [...]
Pfizer CEO Says No ‘Huge Price’ Tag on Vaccine
Pfizer CEO Albert Bourla vowed the company would not "go huge prices" on a coronavirus vaccine, Axios reports. "If we [...]
511 Epidemiologists’ Forecast on Common Activities
A recent New York Times Upshot article offers insight into when hundreds of epidemiologists expect they'll resume 20 common activities [...]
Risks vs Rewards of Fast-Tracked Drug Evaluations
A recent article on Pharmacy Times outlines some of the risks and rewards of fast-tracking drug evaluations in the midst [...]
Research Finds Changes in Consumer Health Care Utilization
New research by Leede Research suggests roughly 72 percent of U.S. consumers have significantly changed their use of health care [...]
New Report Explores COVID-19 Implications for Pharma
A new FirstWord report explores how the COVID-19 could impact the pharmaceutical industry. The report, "COVID-19 implications for pharma: US [...]
Report: High Drug Prices Could Threaten Access to Coronavirus Treatments
Pharmaceutical companies' high pricing could threaten access to potential COVID-19 treatments, The Guardian reports. Sofosbuvir, a hepatitis C drug, costs [...]
Will Expanded Access to Telehealth Services Stay Put?
While the Trump administration's sweeping reimbursement changes led to expanded telehealth services and access, some are concerned about their longevity, [...]
Webinar Series to Look at What’s Ahead for Payers
FierceHealthPayer is planning to host a webinar series on what's in store for payers as the world continues to grapple [...]
Cigna Offering Digital Support for Members with COVID-19
Health insurer Cigna is partnering with Collective Medical and Medocity to offer a new, real-time support tools to help members [...]
Studies Offer Insight into Coronavirus Deaths
Two recent studies suggest people dying of COVID-19 could have gone on to live for, on average, another decade, The [...]
Article: Health Jobs No Longer Recession Proof
While health care jobs have been generally considered recession-proof, the COVID-19 pandemic is breaking that trend, according to a recent [...]
ICER Outlines Alternative Models for Judging Price of COVID-19 Treatments
The Institute for Clinical and Economic Review (ICER) recently recommended two alternative models for judging the "fairness" of pricing for [...]
Blog Considers Cost of Flattening the Curve
A recent blog post on The Incidental Economist highlights the economic costs of the current shutdown spurred by COVID-19. The [...]
Report: Pandemic Causes Hangups in RWD Studies
The COVID-19 pandemic has led to several new real-world data projects, but it has also forced other projects to halt [...]
Podcast Discusses Impact of Pandemic on PCPs
Brent Tree Family Physicians Founder Guy Culpepper in a Relentless Health Value podcast discusses how the COVID-19 pandemic is impacting [...]
ISPOR Launches COVID-19 News Service
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has launched a new, COVID-19-focused service to supplement its main site. [...]
Preparing for a COVID-19 Vaccine
A recent Health Affairs blog post considers the challenges that lie ahead of a potential COVID-19 vaccine. The rollout of [...]
Column Considers Drug Pricing in U.S., COVID-19 Vaccine
A recent column published in the Los Angeles Times looks at how the U.S. handles drug pricing, and what that [...]
Report: Jaguar Health Triples Price of Drug After Seeking Expanded Use
Jaguar Health this month tripled the price of Mytesi after asking the FDA to expand its use to coronavirus patients, [...]
